WEDNESDAY, Jan. 26, 2022 (HealthDay News) — Although they report difficulty breathing and discomfort while wearing a face mask, most people with asthma still use them in public places during the COVID-19 pandemic, a new study finds. University of Illinois Chicago researchers conducted an online survey of more than 500Continue Reading

FRIDAY, Jan. 21, 2022 (HealthDay News) — Some kids might be able to get over their peanut allergy if they start immunotherapy while they’re still toddlers, a major new clinical trial reports. In the trial, a group of 1- to 3-year-olds with severe peanut allergies were safely fed gradually increasingContinue Reading

TUESDAY, Jan. 11, 2022 (HealthDay News) — Secondhand vapor from electronic cigarettes is harmful to others, causing bronchitis symptoms and shortness of breath in young bystanders, a new study reports. Secondhand exposure to vapor increased teens’ risk of bronchitis symptoms by 40% and shortness of breath by 53%, according toContinue Reading

FRIDAY, Jan. 7, 2022 (HealthDay News) — A review of cases from 465 U.S. hospitals underscores the protection provided by COVID-19 vaccines. The new review — by researchers at the U.S. National Institutes of Health — found that vaccinated adults who got breakthrough infections rarely got severely ill. Respiratory failure,Continue Reading

FRIDAY, Dec. 10, 2021 (HealthDay News) — “Fights off tumors and alleviates symptoms of chemotherapy,” one vape’s advertising claims, while another is touted as an “asthma remedy, ADHD remedy, and dementia treatment.” Don’t believe the hype. Despite claims that certain vaping products may alleviate health problems, there’s no proof thatContinue Reading

THURSDAY, Dec. 9, 2021 (HealthDay News) — Children with hard-to-control asthma may get relief from adding an injectable antibody drug to their standard treatment, a clinical trial has found. The drug, called dupilumab (Dupixent), has been available for several years to treat stubborn asthma in adults and teenagers. Based onContinue Reading